Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 242 Lung Neoplasms 59 Neoplasms 57 Head and Neck Neoplasms 57 Stomach Neoplasms 56 Squamous Cell Carcinoma of Head and Neck 48 Parkinson Disease 4, Autosomal Dominant Lewy Body 44 Neoplasm Metastasis 40 Small Cell Lung Carcinoma 38 Urinary Bladder Neoplasms 28 Uterine Cervical Neoplasms 26 Esophageal Neoplasms 25 Colorectal Neoplasms 24 Cholangiocarcinoma 24 Biliary Tract Neoplasms 24 Carcinoma 23 Ovarian Neoplasms 21 Carcinoma, Transitional Cell 18 Carcinoma, Squamous Cell 17 Recurrence 16 Esophageal Squamous Cell Carcinoma 16 Melanoma 13 Breast Neoplasms 13 Non-Squamous Non-Small Cell Lung Cancer 12 Mesothelioma, Malignant 12 Mesothelioma 12 Nasopharyngeal Carcinoma 11 Endometrial Neoplasms 11 Adenocarcinoma 11 Gallbladder Neoplasms 10

Interventions

Nivolumab 5 Ipilimumab 3 relatlimab 1 daratumumab 1 Fluorouracil 1 Cisplatin 1 BMS-986115 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Various Advanced Cancer × Cisplatin × Clear all

NCT03143153 2026-02-17

CheckMate 648

Bristol-Myers Squibb

Phase 3 Completed

970 enrolled 15 charts 1 FDA

Various Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡